CASI Pharmaceuticals
CASI
#10191
Rank
HK$0.13 B
Marketcap
HK$6.42
Share price
-3.06%
Change (1 day)
-73.21%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): -HK$21.61

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$21.57. In 2024 the company made an earnings per share (EPS) of -HK$19.94 a decrease over its 2023 EPS that were of -HK$15.73.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$21.618.38%
2024-HK$19.9426.73%
2023-HK$15.73-32.89%
2022-HK$23.4411.9%
2021-HK$20.95-38.44%
2020-HK$34.04-8.96%
2019-HK$37.3850%
2018-HK$24.9277.78%
2017-HK$14.025.88%
2016-HK$13.24-22.73%
2015-HK$17.13-76.09%
2014-HK$71.65318.18%
2013-HK$17.13-71.79%
2012-HK$60.7565.96%
2011-HK$36.61-50%
2010-HK$73.21-18.97%
2009-HK$90.35-63.64%
2008-HK$248.453.57%
2007-HK$239.88-60.56%
2006-HK$608.2797.22%
2005-HK$308.42-2.7%
2004-HK$316.99-45.59%
2003-HK$582.57-61.8%
2002-HK$1,525-25.52%
2001-HK$2,048-21.38%
2000-HK$2,60413.86%
1999-HK$2,287149.53%
1998-HK$916.7098.15%
1997-HK$462.6310.2%
1996-HK$419.80